SpyGlass Pharma completes $90 Million Series C financing to advance novel treatments for glaucoma and other chronic ophthalmic diseases

SpyGlass Pharma, co-founded by University of Colorado Department of Ophthalmology professor and Slater Family Endowed Chair Malik Kahook, MD, announced closing $90 million in Series C financing to help support clinical trials of its drug delivery system in the United States.